If you hate needles but need a vaccination, MIT might have your back. A recent MIT News article discussed the development of a new type of vaccination that is inhaled directly into the lungs to increase immune responses to respiratory infections or lung cancer. Mucosal surfaces, such as the lining of the respiratory tract, are often the host for viruses. A team of researchers at MIT created a strategy to build up an army of T cells that waits on such surfaces to offer a quick response to viruses.
MIT is Developing Vaccination by Inhalation
The new method creates an army of T cells on a mucosal surface that attack viruses.
Mar 31, 2021
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
